PharmaCyte Biotech (PMCB) Metrics: History & Chart

PharmaCyte Biotech, Inc.(PMCB)

Biotechnology · Las Vegas, NV

$0.42+0.03 (+8.28%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. is a biotechnology firm dedicated to the development and commercialization of advanced cellular therapies within the United States. Their primary therapeutic areas include various forms of cancer, diabetes, and malignant ascites. Central to their efforts is Cell-in-a-Box, their proprietary encapsulation technology which utilizes cellulose to enclose live cells. This innovative platform serves as the foundation for treatments aimed at diverse cancers, such as advanced and inoperable pancreatic cancer, as well as diabetes. The company's pipeline includes therapies for pancreatic and other solid cancerous tumors; a treatment for Type 1 and insulin-dependent Type 2 diabetes involving encapsulated, genetically modified insulin-producing cells; and cancer treatments derived from cannabis plant compounds. To further its research, PharmaCyte maintains collaborative agreements: one with the University of Technology, Sydney, for the creation of melligen cells to combat diabetes, and another with the University of Northern Colorado, focusing on methods for identifying, separating, and quantifying cannabis constituents. Originally established in 1996, the company operated under the name Nuvilex, Inc. before rebranding as PharmaCyte Biotech, Inc. in January 2015. Its corporate headquarters are located in Las Vegas, Nevada.

Las Vegas, NV

2 employees

pharmacyte.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Joshua N. Silverman

View full financials

Third-Party DCF Estimate (FMP)	$2.22
Price Gap vs Third-Party Estimate	+440.63%

7D Total Return	-7.10%
30D Total Return	-19.82%
YTD Total Return	-46.12%
1Y Total Return	-62.49%
3Y Total Return	-80.88%
5Y Total Return	-87.08%
10Y Total Return	-99.39%
15Y Total Return	N/A
20Y Total Return	N/A

2026	-46.12%
2025	-53.89%
2024	-27.31%
2023	-26.28%
2022	+17.20%
2021	-75.94%
2020

CAGR TTM	-62.31%
CAGR 3Y	-42.38%
CAGR 5Y	-33.59%
CAGR 10Y	-39.91%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	0.33
PE Ratio Avg TTM	1.25
PE Ratio Avg 3Y	1.25
Current VS TTM Avg	-73.68%
Current VS 3Y Avg	-73.68%
Current VS 5Y Avg	-73.68%

All Metrics

PMCB Valuation Metrics

PMCB Stock Price Metrics

PMCB Dividend Metrics

PMCB Growth Rate Metrics

PMCB Discounted Cash Flow Metrics

PMCB Returns By Period

PMCB Yearly Returns

PMCB Average Annual Returns By Period (CAGR)

PMCB Revenue Metrics

PMCB PE Ratio Metrics

PMCB PS Ratio Metrics

PMCB PB Ratio Metrics

PMCB Price to Free Cash Flow Ratio Metrics

PMCB Debt to Equity Ratio Metrics

PMCB PEG Ratio Metrics

PMCB FCF Yield

PMCB Earnings Yield

PMCB EBITDA Yield

PMCB OCF Yield

PMCB EV/EBIT Ratio Metrics

PMCB EV/EBITDA Ratio Metrics

PMCB EV/Assets Ratio Metrics

PMCB EV/Sales Ratio Metrics

PMCB Current Ratio Metrics

PMCB Quick Ratio Metrics

PMCB ROIC Metrics

PMCB Return on Assets Metrics

PMCB Return on Equity Metrics

PMCB Net Profit Margin Metrics

PMCB Gross Profit Margin Metrics

PMCB Tax Rate Metrics

PS Ratio	10465.11
PS Ratio Avg TTM	3681.04
PS Ratio Avg 3Y	3681.04
Current VS TTM Avg	+184.30%
Current VS 3Y Avg	+184.30%
Current VS 5Y Avg	+184.30%

PB Ratio	0.15
PB Ratio Avg TTM	0.16
PB Ratio Avg 3Y	0.31
Current VS TTM Avg	-6.32%
Current VS 3Y Avg	-52.28%
Current VS 5Y Avg	-66.21%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	301.94%
Earnings Yield Avg TTM	81.96%
Earnings Yield Avg 3Y	81.96%
Current VS TTM Avg	+268.39%
Current VS 3Y Avg	+268.39%
Current VS 5Y Avg	+268.39%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.43
Ev/Assets Ratio Avg TTM	2.56
Ev/Assets Ratio Avg 3Y	5.63
Current VS TTM Avg	-83.20%
Current VS 3Y Avg	-92.37%
Current VS 5Y Avg	-93.43%

Ev/Sales Ratio	10499.14
Ev/Sales Ratio Avg TTM	3707.31
Ev/Sales Ratio Avg 3Y	3707.31
Current VS TTM Avg	+183.20%
Current VS 3Y Avg	+183.20%
Current VS 5Y Avg	+183.20%

Current Ratio	40.30
Current Ratio Avg TTM	26.10
Current Ratio Avg 3Y	10.47
Current VS TTM Avg	+54.37%
Current VS 3Y Avg	+284.81%
Current VS 5Y Avg	-4.37%

Quick Ratio	40.30
Quick Ratio Avg TTM	26.10
Quick Ratio Avg 3Y	10.47
Current VS TTM Avg	+54.37%
Current VS 3Y Avg	+284.81%
Current VS 5Y Avg	-4.37%

ROIC	(19.51%)
ROIC Avg 3Y	(11.89%)
ROIC Avg 5Y	(9.98%)
Current VS 3Y Avg	-64.03%
Current VS 5Y Avg	-95.40%
Current VS 10Y Avg	+56.24%

ROA	(43.98%)
ROA Avg TTM	(10.74%)
ROA Avg 3Y	(5.67%)
Current VS TTM Avg	-309.61%
Current VS 3Y Avg	-675.67%
Current VS 5Y Avg	-1064.11%

ROE	(54.15%)
ROE Avg TTM	(28.55%)
ROE Avg 3Y	4.30%
Current VS TTM Avg	-89.66%
Current VS 3Y Avg	-1358.94%
Current VS 5Y Avg	-1013.50%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A